Commentary: Overcoming "Founders' Syndrome" to find start-up success
This article was originally published in Scrip
Executive Summary
The current downturn has done little to dampen our naturally entrepreneurial spirit, and if we look around the life sciences sector today there is no shortage of inventive people willing to risk everything they have on that next great drug discovery. However, global research shows that for every 20 life sciences start-ups that get off the ground, 19 fail to stay in the air; never reaching commercial viability, let alone business maturity. Nick Stephens, CEO of global life sciences recruitment specialists RSA, offers insight into why so many promising companies fail, and what can be done to avoid this all too familiar fate.